Now the company has ticked the TGA box off the list we really need an update on the FDA approval for Nerve.
From the quarterly comment below.
Anyone spoken to management on when we should expect an update?
Commenced interactions with the US FDA regarding the US regulatory pathway for Remplir™, data to support expedited review and reimbursement positioning.
US FDA regarding the US regulatory pathway for Remplir™
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $83.73M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.5¢ | 40.0¢ | $44.65K | 111.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9918 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 61349 | 3 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| OCC (ASX) Chart |